FDA Drugs recall ·

Xelstrym (dextroamphetamine) transdermal system… recall

Recall number
D-0055-2025
Date
(initiated October 31, 2024)
Company / brand
Noven Pharmaceuticals Inc
11960 Sw 144th St, Miami, FL, United States
Category
Drugs › Class II
Classification
Class II
Status
Ongoing
Units affected
685 boxes
Initiated by
Voluntary: Firm initiated

Read the official FDA notice ↗

Product

Xelstrym (dextroamphetamine) transdermal system, 13.5 mg dextroamphetamine/9 hours, 30 individually sealed transdermal patches, inside a foil-sealed polypropylene tray, packed in a paper carton/box, MANUFACTURED BY NOVEN PHARMACEUTICALS, INC., Miami, FL 33186 United Sates, NDC 68968-0215-3

Why was it recalled?

Defective Delivery System: The product does not meet predetermined specifications for Coldflow (adhesive).

What should you do?

FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.

Product codes & lot numbers

Lot # 95598, Exp 02/28/25

Distribution

USA nationwide.

What does Class II mean?

Class II means use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious harm is remote.

Source: FDA (drugs), recall D-0055-2025. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.